CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Open-market sale Chief Executive Officer sold 360,540 shares at an average $7.96 ($2,871,124)
- 4 Open-market sale Chief Medical Officer sold 12,239 shares at $8.00 ($97,912)
- 4 Open-market sale Chief Financial Officer sold 118,013 shares at an average $7.96 ($939,612)
- 4 Open-market sale EVP, General Counsel sold 122,479 shares at an average $7.96 ($975,223)
- 4 Open-market sale Chief Operating Officer sold 124,893 shares at an average $7.96 ($994,425)
- 4 Open-market buy Director bought 1,600,000 shares at an average $7.95 ($12,713,126)
- 4 Open-market buy Director bought 1,200,000 shares at an average $9.02 ($10,822,000)
- 4 Grant or award Director acquired 12,135 shares (grant or award)
- 4 Grant or award Director acquired 12,135 shares (grant or award)
- 4 Grant or award Director acquired 20,631 shares (grant or award)
- 4 Grant or award Director acquired 12,135 shares (grant or award)
- 4 Grant or award Director acquired 12,135 shares (grant or award)
- 4 Open-market sale Director sold 4,557 shares at $8.43 ($38,416)
- 4 Open-market sale Director sold 5,241 shares at $8.43 ($44,182)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Open-market sale Chief Commercial Officer sold 18,249 shares at $5.31 ($96,902)
- 4 Open-market sale Director sold 520 shares at $5.74 ($2,985)
Page 3 of 10 · 184 filings